AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...

Group regulatory expectations into a small set of stable control families and types, then run your program around those, not around clauses, articles and acronyms.

How AI is uniting regulatory strategy and biomanufacturing.AI is no longer a futuristic add-on in the life sciences. It is rapidly becoming infrastructure.

While working on a project that involved super-thin prints, [Julius Curt] came up with selective ironing, a way to put designs on the top surface of a print without adding any height. For those ...

Purpose: Hunter syndrome (Mucopolysaccharidosis II) is a rare, X-linked disorder of glycosaminoglycan metabolism. It is caused by a deficiency in the lysosomal enzyme iduronate-2-sulfatase, and in ...